Seegene unveils 'back-to-normal' strategies against pandemic

By LabPulse.com staff writers

January 14, 2022 -- Seegene recently unveiled three new strategies in an attempt to plan for "back-to-normal" global conditions against the COVID-19 pandemic. The company presented the plans at this week's 40th annual J.P. Morgan Healthcare virtual conference.

Seegene's three-pronged strategy includes the following:

  • Mass testing with the company's MDx system at various facilities including schools, airports, workplaces, and others
  • Centralized screening with the company's new diagnostic test, which Seegene says can multiply the test capacity without additional instrument investments in laboratories
  • Testing for patients with respiratory symptoms

Seegene offers the Allplex RV Master Assay, which the company says can differentiate 10 targets at the same time, including COVID-19, flu, and common respiratory viruses.

The MDx platform uses artificial intelligence and allows platform users, regardless of knowledge and experience in MDx, to develop real-time polymerase chain reaction (PCR) assays.

Seegene launches automated PCR testing unit at AACC 2021
Molecular diagnostics developer Seegene is launching a new, automated, real-time polymerase chain reaction (PCR) system called STARlet-AIOS: All-in-One...
Seegene unveils SARS-CoV-2 variant detection test
Seegene has launched its Allplex SARS-CoV-2 Variants II Assay, a multiplex polymerase chain reaction test kit that can screen for six SARS-CoV-2 variants...
Bio-Rad partners with Seegene
Bio-Rad Laboratories announced a partnership with South Korean molecular diagnostics company Seegene to develop and commercialize new diagnostic products...
FDA grants emergency authorization for Seegene COVID-19 test
South Korean firm Seegene has received emergency use authorization from the U.S. Food and Drug Administration (FDA) for its Allplex COVID-19 assay.
Health Canada approves Seegene COVID-19 assay
South Korean firm Seegene has secured Health Canada approval for its Allplex 2019-nCoV assay, a real-time reverse transcription polymerase chain reaction...

Copyright © 2022 LabPulse.com

Last Updated ls 1/14/2022 3:41:42 PM



Subscribe Today
Do you want to be a Microbiology Insider?

When LabPulse gets hot new information, our Insiders are the first to find out. Stay current in today's competitive market by receiving our exclusive free email updates.

Yes, Keep Me Current